Evofem Biosciences, Inc. Made Headway

Wed, Oct 26, 2022 at 07:30 PM
Evofem Biosciences, Inc. Made Headway

Evofem Biosciences, Inc. (EVFM:NASDAQ) shot up at $0.13, representing a gain of 41.3%. On Wed, Oct 26, 2022, EVFM:NASDAQ hit a New 2-Week High of $0.13. The stock got featured on our News Catalysts scanner on Wed, Oct 12, 2022 at 03:15 AM in the 'BIOTECH' category. From Wed, Oct 12, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Aug 05, 2022 at $1.11 with a volume of 39M+.

About Evofem Biosciences, Inc. (EVFM:NASDAQ)

Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.